Search research articles
Contact Us
Filters
Showing results (101-110 of 353) with videos related to
Page
of 36
Sort By:
The Journal of Thoracic and Cardiovascular Surgery
|
June 9, 2005
Assessment of hemostatic activation during cardiopulmonary bypass for coronary artery bypass grafting with bivalirudin: results of a pilot study
Andreas Koster, Ruhi Yeter, Semih Buz, et al.
BMC Nephrology
|
November 20, 2014
Effects of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on renal function in patients with stage 3 chronic kidney disease and type 2 diabetes: a Phase IIb, randomized study
Luis Ruilope, Markolf Hanefeld, A Michael Lincoff, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
July 29, 2010
Drug-eluting stents versus bare-metal stents for treatment of bare-metal in-stent restenosis
Inder M Singh, Steven J Filby, Fredy El Sakr, et al.
Journal of the American College of Cardiology
|
July 29, 2017
Influence of Diabetes on Long-Term Coronary Artery Bypass Graft Patency
Sajjad Raza, Eugene H Blackstone, Penny L Houghtaling, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
November 26, 2009
Clinical outcomes of drug-eluting versus bare-metal in-stent restenosis
Inder M Singh, Steven J Filby, Fredy El Sakr, et al.
American Heart Journal
|
February 3, 2015
Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
Trygve Sørdahl Hall, Jonas Hallén, Mitchell W Krucoff, et al.
Journal of the American College of Cardiology
|
June 12, 2003
Poverty, process of care, and outcome in acute coronary syndromes
Sunil V Rao, Padma Kaul, L Kristin Newby, et al.
Journal of the American College of Cardiology
|
March 27, 2024
Characteristics and Outcomes for Hispanic/Latinx Participants With Statin Intolerance Receiving Bempedoic Acid
Fatima Rodriguez, Leslie Cho, JoAnne Foody, et al.
Circulation. Cardiovascular Interventions
|
August 7, 2014
Association of glycemic control with mortality in patients with diabetes mellitus undergoing percutaneous coronary intervention
Praneet K Sharma, Shikhar Agarwal, Stephen G Ellis, et al.
Journal of the American College of Cardiology
|
September 15, 2004
Lack of clopidogrel pretreatment effect on the relative efficacy of bivalirudin with provisional glycoprotein IIb/IIIa blockade compared to heparin with routine glycoprotein IIb/IIIa blockade: a REPLACE-2 substudy
Jacqueline Saw, A Michael Lincoff, Walter DeSmet, et al.
Page
of 36
Search research articles
Search
Showing results (101-110 of 353) with videos related to
Sort By:
Page
of 36
The Journal of Thoracic and Cardiovascular Surgery
|
June 9, 2005
Assessment of hemostatic activation during cardiopulmonary bypass for coronary artery bypass grafting with bivalirudin: results of a pilot study
Andreas Koster, Ruhi Yeter, Semih Buz, et al.
BMC Nephrology
|
November 20, 2014
Effects of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on renal function in patients with stage 3 chronic kidney disease and type 2 diabetes: a Phase IIb, randomized study
Luis Ruilope, Markolf Hanefeld, A Michael Lincoff, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
July 29, 2010
Drug-eluting stents versus bare-metal stents for treatment of bare-metal in-stent restenosis
Inder M Singh, Steven J Filby, Fredy El Sakr, et al.
Journal of the American College of Cardiology
|
July 29, 2017
Influence of Diabetes on Long-Term Coronary Artery Bypass Graft Patency
Sajjad Raza, Eugene H Blackstone, Penny L Houghtaling, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
November 26, 2009
Clinical outcomes of drug-eluting versus bare-metal in-stent restenosis
Inder M Singh, Steven J Filby, Fredy El Sakr, et al.
American Heart Journal
|
February 3, 2015
Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
Trygve Sørdahl Hall, Jonas Hallén, Mitchell W Krucoff, et al.
Journal of the American College of Cardiology
|
June 12, 2003
Poverty, process of care, and outcome in acute coronary syndromes
Sunil V Rao, Padma Kaul, L Kristin Newby, et al.
Journal of the American College of Cardiology
|
March 27, 2024
Characteristics and Outcomes for Hispanic/Latinx Participants With Statin Intolerance Receiving Bempedoic Acid
Fatima Rodriguez, Leslie Cho, JoAnne Foody, et al.
Circulation. Cardiovascular Interventions
|
August 7, 2014
Association of glycemic control with mortality in patients with diabetes mellitus undergoing percutaneous coronary intervention
Praneet K Sharma, Shikhar Agarwal, Stephen G Ellis, et al.
Journal of the American College of Cardiology
|
September 15, 2004
Lack of clopidogrel pretreatment effect on the relative efficacy of bivalirudin with provisional glycoprotein IIb/IIIa blockade compared to heparin with routine glycoprotein IIb/IIIa blockade: a REPLACE-2 substudy
Jacqueline Saw, A Michael Lincoff, Walter DeSmet, et al.
Page
of 36